← FDA Drug Approvals (Drugs@FDA)

ICOSAPENT ETHYL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QILU · Approved 2024-11-20

Drug application

FDA Application #

ANDA218899

Application type

Abbreviated New Drug Application (Generic)

Brand name

ICOSAPENT ETHYL

Generic name

ICOSAPENT ETHYL

Active ingredients

ICOSAPENT ETHYL

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

QILU

Manufacturer

Qilu Pharmaceutical Co., Ltd.

First approval

2024-11-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown